Ranbaxy Gets USFDA Nod for Two Drugs

Ranbaxy Laboratories on Monday announced that it has received approval from the U.S. Food and Drug Administration to manufacture and market Hydrocodone Bitartrate and Acetaminophen Tablets USP, 75 mg/750 mg, 10 mg/500 mg, 5 mg/500 mg, and 10 mg/325 mg strengths.
India Infoline.com